725-45306-63637
2 vaccinations
5 coded responses
11 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 660 / KS
- Registered
- 2021-04-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-19
Registered in v-safe
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Ocular hyperaemia, Office visit, Periorbital swelling — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Left eye puffy and bloodshot red · Healthcare visit (other): Eye doctorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Headache, Migraine, Ocular hyperaemia, Rash, Rash neonatal — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Extreme migraines and blood shot eye. Bumps around nose and forehead · Healthcare visit (other): Was going to see my doctor but Im going tomorrow headache horrible and fatigued both extremeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-22
Survey response — day 7, dose 2MedDRA: Herpes zoster — Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesFree text: Shingles from shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-05
- 2021-05-12
- 2021-05-19
-
2021-05-26
Survey response — day 42, dose 2MedDRA: Fatigue, Migraine, Pain — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Extreme migraines, body pain, and extremely fatiguedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-14
Survey response — 3 months, dose 2MedDRA: Headache, Herpes zoster, Pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Shingles still have not gone away and headaches and body pain from Covid shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-13
- 2022-04-04
- 2022-04-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-19 | Unsuccessful | |
| 2021-04-20 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Left eye puffy and bloodshot red
Healthcare visit (other): Eye doctor
Systemic reaction (other): Extreme migraines and blood shot eye. Bumps around nose and forehead
Healthcare visit (other): Was going to see my doctor but Im going tomorrow headache horrible and fatigued both extreme
Release 7 — day 7, dose 2
Systemic reaction (other): Shingles from shot
Release 8 — day 42, dose 2
Symptoms: Extreme migraines, body pain, and extremely fatigued
Release 9 — 3 months, dose 2
Symptoms: Shingles still have not gone away and headaches and body pain from Covid shot
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Fatigue | ✓ | ✓ | ✓ |
| HCVO | Headache | ✓ | ✓ | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SRO | Herpes zoster | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SRO | Periorbital swelling | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash neonatal | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release